2014
Association of circulating cytochrome c with clinical manifestations of antiretroviral-induced toxicity
Langs-Barlow A, Selvaraj S, Ogbuagu O, Shabanova V, Shapiro ED, Paintsil E. Association of circulating cytochrome c with clinical manifestations of antiretroviral-induced toxicity. Mitochondrion 2014, 20: 71-74. PMID: 25435346, PMCID: PMC4304943, DOI: 10.1016/j.mito.2014.11.004.Peer-Reviewed Original Research
2013
Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV‐Infected Children in Accra
Langs-Barlow A, Renner L, Katz K, Northrup V, Paintsil E. Performance of Clinical Criteria for Screening of Possible Antiretroviral Related Mitochondrial Toxicity in HIV‐Infected Children in Accra. AIDS Research And Treatment 2013, 2013: 249171. PMID: 23533730, PMCID: PMC3606755, DOI: 10.1155/2013/249171.Peer-Reviewed Original ResearchMitochondrial Disease CriteriaMitochondrial toxicityNaïve childrenCharts of HIVHAART naïve childrenResource-poor settingsHAART exposureHAART initiationHIV diagnosisHIV infectionTherapy toxicityHIV managementClinical symptomsProspective studyClinical criteriaDisease criteriaHAARTYounger ageHIVMitochondrial damageSignificant differencesChildrenToxicityScoresExposure
2011
Time to and Predictors of CD4+ T‐Lymphocytes Recovery in HIV‐Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana
Renner L, Prin M, Li FY, Goka B, Northrup V, Paintsil E. Time to and Predictors of CD4+ T‐Lymphocytes Recovery in HIV‐Infected Children Initiating Highly Active Antiretroviral Therapy in Ghana. AIDS Research And Treatment 2011, 2011: 896040. PMID: 21738861, PMCID: PMC3124224, DOI: 10.1155/2011/896040.Peer-Reviewed Original ResearchT-lymphocyte recoveryPredictors of CD4Resource-limited settingsHAART initiationKorle-Bu Teaching HospitalMost resource-limited settingsCox proportional hazards modelT-lymphocyte countsActive antiretroviral therapyMedian recovery timeProportional hazards modelPredictors of timeComplete CD4Percent CD4Antiretroviral therapyActive antiretroviralsMean ageTeaching hospitalT lymphocytesCD4Hazards modelHIVChildrenAgeSignificant predictor variables